Protocol Ledger

NCT03742297 · Phase III · ACTIVE NOT RECRUITING

Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

Interventional Phase III clinical trial protocol NCT03742297 sponsored by PETHEMA Foundation in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-10-22 Enrollment: 462 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03742297
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)462 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03742297
Protocol FieldVerified Registry Value
NCT IdentifierNCT03742297
Consolidated Lead SponsorPETHEMA Foundation
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment462 participants (ACTUAL)
Registered Start Date2018-10-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI